Antidepressant fluoxetine and its potential against colon tumors
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 6 (1) , 11-21
Abstract
Antidepressant fluoxetine and its potential against colon tumorsKeywords
This publication has 100 references indexed in Scilit:
- Mitochondrial Genome Instability and ROS Enhance Intestinal Tumorigenesis in APC MiceThe American Journal of Pathology, 2012
- Inhibition of aldose reductase prevents angiogenesis in vitro and in vivoAngiogenesis, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancerJournal of Experimental Medicine, 2010
- Colorectal cancer risk in relation to antidepressant medication useInternational Journal of Cancer, 2010
- Colorectal cancerThe Lancet, 2010
- Antidepressant use and colorectal cancer riskPharmacoepidemiology and Drug Safety, 2009
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activityNature, 2008
- Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cellsEuropean Journal of Pharmacology, 2006
- PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomasJournal of Cancer Research and Clinical Oncology, 2005